Eli Lilly's (LLY) acquisition of Morphic (MORF) is set to expand its immunology pipeline by adding the latter's lead candidate, MORF-057, which is being developed for IBD conditions.
Zacks via Yahoo
11 hours ago
Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know
3 hours ago
ShareCast
Eli Lilly to acquire Morphic via tender offer
1 day ago
Proactive Financial News
Eli Lilly weight-loss drug found more effective than Novo Nordisk's Ozempic
14 hours ago
USA TODAY Sports - Golfweek via Yahoo
Keegan Bradley on being named 2025 U.S. Ryder Cup captain: ‘I don’t think I’ll ever be more surprised with anything in my life’
7 hours ago
Yahoo Finance
Eli Lilly awaits head-to-head study on GLP-1s after new report reaffirms superiority
8 hours ago
View all
Belgian high-voltage transmission system operator
elia.be
Elia is a Belgian transmission system operator for high-voltage electricity, located in Brussels, Belgium. It operates in Belgium and Germany. Wikipedia